Follow us on Twitter Follow us on LinkedIn Follow us on Instagram
Daily construction news
Weekly plant news

Construction News

Thu May 24 2018

Related Information
Related Information
Related Information

News » International » SNC-Lavalin picked for Quebec biotech HQ » published 21 Jul 2016

SNC-Lavalin picked for Quebec biotech HQ

SNC-Lavalin has won a CA$12.5m (£7.3m) design contract for a major new biopharmacutical facility in Quebec City, Canada.

The new facility will regroup Medicago’s head office and consolidate all its current Canadian operations at an innovation park in the city. The headquarters will house research and development activities and commercial production in the city's Espace d'innovation D'Estimauville.

Once complete, the 44,000m2, fully automated facility will house manufacturing, offices, laboratories, a greenhouse, a pilot plant and support services.  Construction is expected to begin in the autumn of this year.   

“Our relationship with Medicago dates back to 2008,” said Ian Edwards, president, infrastructure, SNC-Lavalin. “We are very proud to be part of a local project that, once complete, will export vaccines to foreign markets and help Canada meet its seasonal and pandemic flu vaccine needs.”



Download our free construction news iPhone / iPad app. Sign up to our FREE email newsletters or subscribe to our RSS feed for regular updates on the latest Construction News, Plant News & Contract News. The Construction Index also provides the latest Construction Tenders, Construction Market Data & Construction Law Commentary all FREE.

This article was published on 21 Jul 2016 (last updated on 21 Jul 2016).

More News Channels